Viewing Study NCT02419495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2026-02-10 @ 1:04 PM
Study NCT ID: NCT02419495
Status: TERMINATED
Last Update Posted: 2025-06-04
First Post: 2015-04-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Clinical Stage III Cutaneous Melanoma AJCC v8 View
None Clinical Stage IV Cutaneous Melanoma AJCC v8 View
None Fallopian Tube Carcinoma View
None Metastatic Lung Non-Small Cell Carcinoma View
None Metastatic Malignant Solid Neoplasm View
None Metastatic Melanoma View
None Metastatic Renal Cell Carcinoma View
None Ovarian Carcinoma View
None Pathologic Stage III Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IIID Cutaneous Melanoma AJCC v8 View
None Pathologic Stage IV Cutaneous Melanoma AJCC v8 View
None Primary Peritoneal Carcinoma View
None Stage III Lung Cancer AJCC v8 View
None Stage III Renal Cell Cancer AJCC v8 View
None Stage IIIA Lung Cancer AJCC v8 View
None Stage IIIB Lung Cancer AJCC v8 View
None Stage IIIC Lung Cancer AJCC v8 View
None Stage IV Lung Cancer AJCC v8 View
None Stage IV Renal Cell Cancer AJCC v8 View
None Stage IVA Lung Cancer AJCC v8 View
None Stage IVB Lung Cancer AJCC v8 View
None Triple-Negative Breast Carcinoma View
None Unresectable Lung Non-Small Cell Carcinoma View
None Unresectable Melanoma View
None Unresectable Renal Cell Carcinoma View
Keywords: